Assembly Biosciences (ASMB) EBT Margin Growth (1y) (2018 - 2026)

Assembly Biosciences (ASMB) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Assembly Biosciences 282.74 Mn 56.14 Mn - -3,643.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,643.00
Dec 31, 2025 19,353.00
Sep 30, 2025 5,520.00
Jun 30, 2025 1,999.00
Mar 31, 2025 5,092.00
Dec 31, 2024 1,106.00
Sep 30, 2021 -42,147.00
Dec 31, 2020 -321,746.00
Sep 30, 2020 58,144.00
Jun 30, 2020 61,957.00
Mar 31, 2020 4,335.00
Dec 31, 2019 8,623.00
Sep 30, 2019 -8,852.00
Jun 30, 2019 23,295.00
Mar 31, 2019 -24,071.00
Dec 31, 2018 -30,939.00
Sep 30, 2018 -3,989.00
Jun 30, 2018 -25,464.00
Mar 31, 2018 1.36 Mn